These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 2618654)

  • 41. [Adoptive immunotherapy by intra-arterial infusion of ATLAK or Allo-TLAK cells in patients with head and neck cancer].
    Ikawa T; Eura M; Fukiage T; Murakami H; Yamasaki S; Fukuda K; Fukushima M; Arishima S; Maehara T; Ishikawa T
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1438-47. PubMed ID: 2786378
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Systematic preclinical study on the therapeutic properties of recombinant human interleukin 2 for the treatment of metastatic disease.
    Talmadge JE; Phillips H; Schindler J; Tribble H; Pennington R
    Cancer Res; 1987 Nov; 47(21):5725-32. PubMed ID: 3499218
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Polymer chemotherapy for head and neck cancer.
    Shikani AH; Domb AJ
    Laryngoscope; 2000 Jun; 110(6):907-17. PubMed ID: 10852503
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Endogenous and adoptively transferred A-NK and T-LAK cells continuously accumulate within murine metastases up to 48 h after inoculation.
    Hokland M; Kjaergaard J; Kuppen PJ; Nannmark U; Agger R; Hokland P; Basse P
    In Vivo; 1999; 13(3):199-204. PubMed ID: 10459491
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Role of nitric oxide in the development of distant metastasis from squamous cell carcinoma.
    Scher RL
    Laryngoscope; 2007 Feb; 117(2):199-209. PubMed ID: 17277613
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Adoptive immunotherapy by pantropic killer cells recovered from OK-432-injected tumor sites in mice.
    Saito M; Nanjo M; Kataoka M; Moriya Y; Sugawara Y; Yoshida T; Ishida N
    Cancer Res; 1988 Aug; 48(15):4163-7. PubMed ID: 3390809
    [TBL] [Abstract][Full Text] [Related]  

  • 47. TGF-alpha antisense gene therapy inhibits head and neck squamous cell carcinoma growth in vivo.
    Endo S; Zeng Q; Burke NA; He Y; Melhem MF; Watkins SF; Lango MN; Drenning SD; Huang L; Rubin Grandis J
    Gene Ther; 2000 Nov; 7(22):1906-14. PubMed ID: 11127578
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunotherapy with effector cells and IL-2 of lymph node metastases of human squamous-cell carcinoma of the head and neck established in nude mice.
    Chikamatsu K; Reichert TE; Kashii Y; Saito T; Kawashiri S; Yamamoto E; Whiteside TL
    Int J Cancer; 1999 Aug; 82(4):532-7. PubMed ID: 10404067
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Successful immunotherapy of murine experimental hepatic metastases with lymphokine-activated killer cells and recombinant interleukin 2.
    Lafreniere R; Rosenberg SA
    Cancer Res; 1985 Aug; 45(8):3735-41. PubMed ID: 3893689
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interleukin 2 gene transfer prevents NKG2D suppression and enhances antitumor efficacy in combination with cisplatin for head and neck squamous cell cancer.
    Li D; Ronson B; Guo M; Liu S; Bishop JS; Van Echo DA; O'Malley BW
    Cancer Res; 2002 Jul; 62(14):4023-8. PubMed ID: 12124336
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Elimination of established liver metastases by human interleukin 2-activated natural killer cells after locoregional or systemic adoptive transfer.
    Okada K; Nannmark U; Vujanovic NL; Watkins S; Basse P; Herberman RB; Whiteside TL
    Cancer Res; 1996 Apr; 56(7):1599-608. PubMed ID: 8603408
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Modification of lymphokine-activated killer cell accumulation into tumor sites by chemotherapy, local irradiation, or splenectomy.
    Kawata A; Hosokawa M; Sawamura Y; Ito K; Une Y; Shibata T; Uchino J; Kobayashi H
    Mol Biother; 1990 Dec; 2(4):221-7. PubMed ID: 2288722
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Combined vaccination with major histocompatibility class I and interleukin 2 gene-transduced melanoma cells synergizes the cure of postsurgical established lung metastases.
    Porgador A; Tzehoval E; Vadai E; Feldman M; Eisenbach L
    Cancer Res; 1995 Nov; 55(21):4941-9. PubMed ID: 7585534
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cure of an established nonimmunogenic tumor, SCC VII, with a novel interleukin 12-based immunotherapy regimen in C3H mice.
    Mandpe AH; Tsung K; Norton JA
    Arch Otolaryngol Head Neck Surg; 2003 Jul; 129(7):786-92. PubMed ID: 12874083
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Adoptive T cell transfer augments IL-2 mediated tumour regression in a HNSCC xenograft nude mouse model.
    Ambade A; Mulherkar R
    Cancer Lett; 2008 Dec; 272(2):316-24. PubMed ID: 18762367
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antitumor and antiangiogenic effects of interleukin 12 gene therapy in murine head and neck carcinoma model.
    Imagawa Y; Satake K; Kato Y; Tahara H; Tsukuda M
    Auris Nasus Larynx; 2004 Sep; 31(3):239-45. PubMed ID: 15364358
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunotherapy of mice with a large burden of disseminated lymphoma with low-dose interleukin 2.
    Maas RA; Dullens HF; De Jong WH; Den Otter W
    Cancer Res; 1989 Dec; 49(24 Pt 1):7037-40. PubMed ID: 2582444
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Adoptive immunotherapy of human pancreatic cancer with lymphokine-activated killer cells and interleukin-2 in a nude mouse model.
    Marincola FM; Da Pozzo LF; Drucker BJ; Holder WD
    Surgery; 1990 Nov; 108(5):919-29. PubMed ID: 2237773
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Generation of therapeutic T cells from draining lymph nodes in a murine model of head and neck squamous cell carcinoma.
    Sadeghi N; Black MJ; Hier MP; Shenouda G; Karp SE
    Arch Otolaryngol Head Neck Surg; 1997 Jan; 123(1):25-30. PubMed ID: 9006500
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [The effect of IL-2 injection around the metastatic cervical lymphnode].
    Ogasawara H; Takeda N; Takeda N; Kumoi T
    Nihon Gan Chiryo Gakkai Shi; 1990 Jun; 25(6):1119-22. PubMed ID: 2398297
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.